53 related articles for article (PubMed ID: 1812176)
1. Polyclonal anti-idiotypic antibodies as internal images of dopamine. Applications for biochemical and morphological studies of DA receptors in the rat brain.
Mons N; Dubourg P; Messier C; Chiavaroli C; Calas A; Geffard M
J Hirnforsch; 1991; 32(5):617-25. PubMed ID: 1812176
[TBL] [Abstract][Full Text] [Related]
2. Locomotor bias produced by intra-accumbens and intracaudate injection of polyclonal dopamine anti-idiotypic antibodies.
Mrabet O; Messier C; Mons N; Destrade C; Geffard M
J Hirnforsch; 1991; 32(5):627-33. PubMed ID: 1812177
[TBL] [Abstract][Full Text] [Related]
3. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
Seiler MP; Markstein R
Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
[TBL] [Abstract][Full Text] [Related]
4. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to a brain dopamine binding protein: production, specificity, and immunohistochemistry.
Hsu LL; Moroi K; Lakchaura BD; Chan T; Lin CT; Wu JY
J Neurosci Res; 1987; 17(4):417-23. PubMed ID: 3305971
[TBL] [Abstract][Full Text] [Related]
6. Anti-idiotypes against a monoclonal anti-haloperidol antibody bind to dopamine receptor.
Elazar Z; Kanety H; Schreiber M; Fuchs S
Life Sci; 1988; 42(20):1987-93. PubMed ID: 2966887
[TBL] [Abstract][Full Text] [Related]
7. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
Hancock AA; Marsh CL
Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
[TBL] [Abstract][Full Text] [Related]
8. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
Hersch SM; Yi H; Heilman CJ; Edwards RH; Levey AI
J Comp Neurol; 1997 Nov; 388(2):211-27. PubMed ID: 9368838
[TBL] [Abstract][Full Text] [Related]
9. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
[TBL] [Abstract][Full Text] [Related]
10. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.
Reches A; Burke RE; Kuhn CM; Hassan MN; Jackson VR; Fahn S
J Pharmacol Exp Ther; 1983 Jun; 225(3):515-21. PubMed ID: 6864517
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
Panagopoulos NT; Matsokis NA; Valcana T
J Neurosci Res; 1993 Aug; 35(5):499-506. PubMed ID: 8377223
[TBL] [Abstract][Full Text] [Related]
12. Distribution of dopamine D1 and D2 receptors in rabbit cortical areas, hippocampus, and neostriatum in relation to dopamine contents.
Dewar KM; Reader TA
Synapse; 1989; 4(4):378-86. PubMed ID: 2532424
[TBL] [Abstract][Full Text] [Related]
13. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
[TBL] [Abstract][Full Text] [Related]
14. Studies on aging processes.
Agnati LF; Fuxe K; Benfenati F; Toffano G; Cimino M; Battistini N; Calza L; Merlo Pich E
Acta Physiol Scand Suppl; 1984; 532():45-61. PubMed ID: 6093434
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to adenosine receptor by an auto-anti-idiotypic approach.
Ku HH; Cleveland WL; Erlanger BF
J Immunol; 1987 Oct; 139(7):2376-84. PubMed ID: 3655366
[TBL] [Abstract][Full Text] [Related]
16. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
Bennett JP; Wooten GF
Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
[TBL] [Abstract][Full Text] [Related]
17. [Anti-idiotypic monoclonal antibodies against latrotoxin interact with rat brain synaptosomes and modify latrotoxin-induced calcium entry into synaptosomes].
Pashkov VN; Tsiuriupa GP; Griko NB; Bulgakov OV; Rudenko NV; Iakhnina EB; Grishin EV
Bioorg Khim; 1996 Jun; 22(6):403-7. PubMed ID: 8975667
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural analysis of prefrontal cortical inputs to the rat amygdala: spatial relationships to presumed dopamine axons and D1 and D2 receptors.
Pinto A; Sesack SR
Brain Struct Funct; 2008 Sep; 213(1-2):159-75. PubMed ID: 18340460
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antiidiotypic antibodies against delta opioid receptors as an electron microscopy probe.
Cupo A; Conrath M; Eybalin M; Fourrier O; Zouaoui D; Kaldy P; Herbrecht F
Eur J Cell Biol; 1992 Apr; 57(2):273-84. PubMed ID: 1324839
[TBL] [Abstract][Full Text] [Related]
20. Characterization of anti-peptide antibodies for the localization of D2 dopamine receptors in rat striatum.
McVittie LD; Ariano MA; Sibley DR
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1441-5. PubMed ID: 1825357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
